<?xml version="1.0" encoding="UTF-8"?>
<urlset
  xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://weightlossrankings.org/research/glp-1-pricing-index-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Compounded Pricing Index 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/semaglutide-muscle-mass-loss</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>Semaglutide and Muscle Mass: What the STEP Trial Sub-Analyses Actually Show</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/tirzepatide-vs-semaglutide-head-to-head</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>Tirzepatide vs Semaglutide: A Head-to-Head Look at SURMOUNT and STEP</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/compounded-semaglutide-bioequivalence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>Compounded Semaglutide Bioequivalence: What 503A Pharmacies Actually Have to Test</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/fda-warning-letters-glp1-2025-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letters to Compounded GLP-1 Telehealth Providers: 2025-2026 Investigation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/cheapest-compounded-semaglutide-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>Is $99 Compounded Semaglutide Real? We Verified Every Provider at the Floor Price</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/compounded-glp1-price-movement-12-months</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>How Compounded GLP-1 Prices Moved Over the Last 16 Months: Provider-by-Provider Trajectories</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/what-happens-when-you-stop-semaglutide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>What Happens When You Stop Taking Semaglutide? STEP-4, STEP-1 Extension, and SURMOUNT-4 Tell the Story</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/glp1-insurance-coverage-audit-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Insurance Coverage at the 10 Largest US Insurers: A 2026 Audit</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/glp1-side-effects-what-trials-actually-showed</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Side Effects: A Plain-English Guide to What the Trials Actually Showed</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/wegovy-pen-vs-compounded-vial-practical-differences</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>Wegovy Pen vs Compounded Vial: 12 Practical Differences Before You Switch</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/select-trial-cardiovascular-benefits-non-diabetics</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>What SELECT Showed: Semaglutide Cuts Heart Attack Risk by 20% in Non-Diabetics with Cardiovascular Disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/surmount-osa-tirzepatide-sleep-apnea</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>Tirzepatide for Sleep Apnea: What SURMOUNT-OSA Showed and the FDA&apos;s First-Ever OSA Drug Approval</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/step-teens-semaglutide-adolescents</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>What STEP-TEENS Showed: Semaglutide for Adolescents with Obesity</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/where-to-inject-semaglutide-tirzepatide-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>Where to Inject Semaglutide and Tirzepatide: The Complete Patient Guide</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/how-long-does-glp1-take-to-work</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>How Long Does Semaglutide and Tirzepatide Take to Work? The Trial Data on Onset, Appetite, and Weight Loss Timing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/glp1-storage-shelf-life-refrigeration-guide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Storage Guide: Refrigeration, Room Temperature, Travel, and Expiration for Wegovy, Ozempic, Zepbound, and Mounjaro</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/glp1-pipeline-2026-survodutide-maridebart-ecnoglutide</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>Beyond Wegovy and Zepbound: Three Pipeline GLP-1 Drugs That Could Reach Approval in 2026-2027</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/pcab-accreditation-compounding-pharmacy-investigation</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>PCAB Accreditation: What It Actually Means When a Compounding Pharmacy Has It (and Doesn&apos;t)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/foundayo-orforglipron-fda-approval-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>Foundayo (orforglipron) Approved: The First Once-Daily Oral GLP-1 Pill for Weight Loss</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/cagrisema-redefine-trial-results-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>CagriSema REDEFINE: What Novo Nordisk&apos;s Amylin Combination Actually Showed</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/retatrutide-triple-agonist-evidence-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>Retatrutide: What We Know About Lilly&apos;s Triple Agonist as TRIUMPH-4 Reads Out</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/step-hfpef-semaglutide-heart-failure</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>STEP-HFpEF: How Semaglutide Treats Heart Failure With Preserved Ejection Fraction</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/flow-trial-semaglutide-kidney-disease</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FLOW: How Semaglutide Became the First GLP-1 Approved for Diabetic Kidney Disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/research/glp1-alcohol-use-disorder-evidence-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Drugs and Alcohol Use Disorder: What the Trial Evidence Actually Shows in 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/novo-nordisk-inc-717576</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Novo Nordisk Inc. — Postmarketing Adverse Drug Experience Reporting Requirements</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/join-josie-717986</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Join Josie — Compounded GLP-1 marketing and labeling concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/fitrx-llc-dba-fitrx-717987</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: FitRx LLC — Compounded GLP-1 marketing and labeling concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/kin-meds-721450</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Kin Meds — Compounded GLP-1 marketing and labeling concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/better-health-labs-inc-dba-measured-721454</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Better Health Labs Inc — Compounded GLP-1 marketing and labeling concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/refills-health-llc-dba-refills-health-721475</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Refills Health LLC — Compounded GLP-1 marketing and labeling concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/bluefitmd-721446</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: BlueFitMD — Compounded GLP-1 marketing and labeling concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/premium-health-management-inc-dba-premium-health-721474</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Premium Health Management Inc. — False &amp; Misleading Claims/Misbranded</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/kare-solutions-llc-dba-zappy-717991</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Kare Solutions, LLC — False &amp; Misleading Claims/Misbranded</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/lean-rx-inc-dba-skinnyrx-717989</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Lean Rx, Inc. — False &amp; Misleading Claims/Misbranded</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/strut-health-llc-dba-strut-721448</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Strut Health, LLC — False &amp; Misleading Claims/Misbranded</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/weightless-medical-llc-dba-weightcare-721478</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Weightless Medical LLC — False &amp; Misleading Claims/Misbranded</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/viv-health-inc-dba-viv-rx-721818</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Viv Health, Inc. — False &amp; Misleading Claims/Misbranded</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/zeuss-llc-dba-zeuss-717985</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Zeuss LLC — False &amp; Misleading Claims/Misbranded</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/ivim-services-llc-dba-ivim-721816</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Ivim Services LLC — False &amp; Misleading Claims/Misbranded</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/genogenix-llc-718739</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: GenoGenix LLC — Compounding Pharmacy/Adulterated Drug Products</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://weightlossrankings.org/fda-warning-letters/apothecary-pharma-llc-717972</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letter: Apothecary Pharma, LLC — Compounding Pharmacy/Adulterated Drug Products</news:title>
    </news:news>
  </url>
</urlset>